30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Pediatrix Medical Group Inc (MD)

Track

Over the last 90 days, Pediatrix Medical Group Inc. has seen a net sell-off of $855,665.00 from insiders, with one insider making sales. Notably, Director Shirley A. Weis sold shares valued at $853,143.04. The stock has experienced an 18.1% price increase over the past 90 days, nearing its 52-week high.
Stock chart
Ticker: MD Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Weis Shirley A
2 sales — total 1,708,808 USD
Sale 13 May 2026
Value US$370,297.56 | Price 484.44 | Shares 2,782
Proposed sale 13 May 2026
Value US$4,469,947.56 | Price 52.22 | Shares 74,692
Sale 15 Dec 2025
Value US$3,261,430.00 | Price 421.07 | Shares 17,131
Proposed sale 15 Dec 2025
Value US$3,612,647.25 | Price 343.97 | Shares 69,881
Sale 17 Nov 2025
Value US$240,994.00 | Price 23.00 | Shares 10,478
Proposed sale 17 Nov 2025
Value US$240,994.00 | Price 23.00 | Shares 10,478
Sale 6 Nov 2025
Value US$216,500.00 | Price 21.65 | Shares 10,000
Proposed sale 6 Nov 2025
Value US$216,150.00 | Price 21.62 | Shares 10,000
Proposed sale 21 Feb 2025
Value US$308,093.05 | Price 16.63 | Shares 18,530
Sale 13 Nov 2024
Value US$423,660.00 | Price 15.35 | Shares 27,600
Proposed sale 13 Nov 2024
Value US$427,800.00 | Price 15.50 | Shares 27,600
Sale 8 Nov 2024
Value US$129,728.00 | Price 16.00 | Shares 8,108
Proposed sale 8 Nov 2024
Value US$129,730.50 | Price 16.00 | Shares 8,108
Proposed sale 4 Nov 2024
Value US$1,772,018.93 | Price 14.98 | Shares 118,291
Sale 30 Aug 2024
Value US$119,769.00 | Price 10.79 | Shares 11,100
Proposed sale 30 Aug 2024
Value US$119,756.33 | Price 10.79 | Shares 11,100
Sale 27 Aug 2024
Value US$78,120.00 | Price 11.16 | Shares 7,000
Proposed sale 27 Aug 2024
Value US$78,134.22 | Price 11.16 | Shares 7,000
Sale 12 Aug 2024
Value US$175,775.04 | Price 10.08 | Shares 17,438
Sale 9 Aug 2024
Value US$328,224.96 | Price 10.08 | Shares 32,562
Proposed sale 9 Aug 2024
Value US$502,590.00 | Price 10.05 | Shares 50,000
Proposed sale 9 Aug 2024
Value US$484,158.00 | Price 10.25 | Shares 47,230
Sale 14 Dec 2023
Value US$55,219.12 | Price 9.58 | Shares 5,764
Proposed sale 14 Dec 2023
Value US$55,219.70 | Price 9.58 | Shares 5,764
Sale 14 Dec 2023
Value US$9,331.40 | Price 9.62 | Shares 970
Sale 14 Dec 2023
Value US$11,063.00 | Price 9.62 | Shares 1,150
Sale 14 Jun 2023
Value US$186,549.02 | Price 14.14 | Shares 13,193
Proposed sale 14 Jun 2023
Value US$186,574.54 | Price 14.14 | Shares 13,193
Sale 25 May 2023
Value US$437,580.00 | Price 13.26 | Shares 33,000
Proposed sale 24 May 2023
Value US$446,490.00 | Price 13.53 | Shares 33,000
Sale 19 May 2023
Value US$13,725.41 | Price 13.63 | Shares 1,007
Proposed sale 19 May 2023
Value US$13,725.51 | Price 13.63 | Shares 1,007
Sale 18 May 2023
Value US$243,805.15 | Price 13.55 | Shares 17,993
Proposed sale 18 May 2023
Value US$243,885.22 | Price 13.55 | Shares 17,993
Proposed sale 12 May 2023
Value US$3,074,409.00 | Price 13.50 | Shares 227,734
Proposed sale 10 May 2023
Value US$675,000.00 | Price 13.50 | Shares 50,000
Sale 21 Nov 2022
Value US$342,464.70 | Price 15.45 | Shares 22,166
Sale 7 Nov 2022
Value US$367,440.00 | Price 15.31 | Shares 24,000
Planned sale 11 Jan 2022
Value US$1,066,044.06 | Price 26.58 | Shares 40,107
Planned sale 10 Jan 2022
Value US$1,583,570.92 | Price 26.44 | Shares 59,893
Planned sale 5 Jan 2022
Value US$346,561.38 | Price 27.42 | Shares 12,639
Planned sale 4 Jan 2022
Value US$2,396,312.23 | Price 27.43 | Shares 87,361
Planned sale 31 Dec 2021
Value US$178,278.24 | Price 27.16 | Shares 6,564
Planned sale 10 Nov 2021
Value US$142,250.00 | Price 28.45 | Shares 5,000
Planned sale 10 Nov 2021
Value US$249,744.00 | Price 28.38 | Shares 8,800
Planned sale 29 Oct 2021
Value US$248,225.06 | Price 26.87 | Shares 9,238
Planned sale 28 Oct 2021
Value US$301,223.00 | Price 29.00 | Shares 10,387
Planned sale 4 Oct 2021
Value US$36,830.00 | Price 29.00 | Shares 1,270
Planned sale 10 Aug 2021
Value US$284,647.65 | Price 32.35 | Shares 8,799
Planned sale 1 Apr 2021
Value US$20,183.42 | Price 25.81 | Shares 782
Planned sale 1 Apr 2021
Value US$2,520,137.20 | Price 25.40 | Shares 99,218
Planned sale 4 Jan 2021
Value US$1,265,238.29 | Price 23.89 | Shares 52,961
Planned sale 4 Jan 2021
Value US$1,101,182.99 | Price 23.41 | Shares 47,039
Planned sale 10 Dec 2020
Value US$764,919.22 | Price 23.04 | Shares 33,194
Planned sale 9 Dec 2020
Value US$1,536,671.61 | Price 23.00 | Shares 66,806
Sale 15 Sep 2020
Value US$416,424.80 | Price 18.93 | Shares 22,000
Sale 15 Sep 2020
Value US$190,179.00 | Price 19.02 | Shares 10,000
Planned sale 1 Nov 2019
Value US$114,403.00 | Price 22.88 | Shares 5,000
Planned sale 3 Sep 2019
Value US$104,050.00 | Price 20.81 | Shares 5,000
Buy 12 Aug 2019
Value US$1,306,815.57 | Price 21.35 | Shares 61,204
Buy 12 Aug 2019
Value US$1,306,836.92 | Price 21.35 | Shares 61,205
Buy 9 Aug 2019
Value US$2,680,878.77 | Price 21.52 | Shares 124,553
Buy 9 Aug 2019
Value US$2,680,878.77 | Price 21.52 | Shares 124,553
Buy 8 Aug 2019
Value US$1,392,595.51 | Price 21.68 | Shares 64,243
Buy 8 Aug 2019
Value US$1,392,573.83 | Price 21.68 | Shares 64,242
Sale 13 Mar 2019
Value US$100,330.89 | Price 30.40 | Shares 3,300
Planned sale 7 Mar 2019
Value US$138,984.19 | Price 30.16 | Shares 4,608
Planned sale 1 Mar 2019
Value US$399,197.09 | Price 32.91 | Shares 12,130
Planned sale 1 Mar 2019
Value US$212,262.41 | Price 32.90 | Shares 6,452
Planned sale 20 Feb 2019
Value US$46,690.16 | Price 36.22 | Shares 1,289
Planned sale 22 Jan 2019
Value US$91,500.00 | Price 36.60 | Shares 2,500
Sale 14 Aug 2018
Value US$49,405.00 | Price 48.20 | Shares 1,025
Sale 14 Aug 2018
Value US$74,197.20 | Price 48.18 | Shares 1,540
Sale 14 Aug 2018
Value US$45,038.95 | Price 48.17 | Shares 935
Sale 12 Jun 2018
Value US$647,774.60 | Price 46.46 | Shares 13,942
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-14 2026-05-13 S Sale
2.0
Weis Shirley A
Non-Executive Director
2,782 +43.1%
484.44
US$370,298 		2,782 +43.1% 484.44 US$370,298
2026-05-13 2026-05-13 PrS Proposed sale
2.0
Weis Shirley A

Director

Non-Executive Director
74,692
52.22
US$4,469,948 		74,692 52.22 US$4,469,948
2025-12-17 2025-12-15 S Sale
3.2
ORDAN MARK S

Chief Executive Officer

Executive Director
17,131 +19.4%
421.07
US$3,261,430 		17,131 +19.4% 421.07 US$3,261,430
2025-12-15 2025-12-15 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
23,000
22.50
US$517,500 		23,000 22.50 US$517,500
2025-11-19 2025-11-17 S Sale
2.8
Rucker Michael A.
Non-Executive Director
10,478 -15.1%
23.00
US$240,994 		10,478 -15.1% 23.00 US$240,994
2025-11-17 2025-11-17 PrS Proposed sale
2.8
Rucker Michael A.

Director

Non-Executive Director
10,478
23.00
US$240,994 		10,478 23.00 US$240,994
2025-11-10 2025-11-06 S Sale
2.5
Linynsky Laura A
Non-Executive Director
10,000 -23.7%
21.65
US$216,500 		10,000 -23.7% 21.65 US$216,500
2025-11-06 2025-11-06 PrS Proposed sale
2.5
Laura A Linynsky

Director

Non-Executive Director
10,000
21.62
US$216,150 		10,000 21.62 US$216,150
2025-02-21 2025-02-21 PrS Proposed sale
2.7
Swift James D

Former Officer

Officer
18,530
16.63
US$308,093 		18,530 16.63 US$308,093
2024-11-14 2024-11-13 S Sale
3.2
ORDAN MARK S
Non-Executive Director
27,600 -16.6%
15.35
US$423,660 		27,600 -16.6% 15.35 US$423,660
2024-11-13 2024-11-13 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
27,600
15.50
US$427,800 		27,600 15.50 US$427,800
2024-11-12 2024-11-08 S Sale
3.5
Moore Mary Ann E

EVP, GC, Chief Admin Off & Sec

Officer
8,108 -5.6%
16.00
US$129,728 		8,108 -5.6% 16.00 US$129,728
2024-11-08 2024-11-08 PrS Proposed sale
3.5
Moore Mary Ann E

Officer

Officer
8,108
16.00
US$129,730 		8,108 16.00 US$129,730
2024-11-04 2024-11-04 PrS Proposed sale
0.9
Richards C Marc

Former Officer

Officer
118,291
14.98
US$1,772,019 		118,291 14.98 US$1,772,019
2024-09-03 2024-08-30 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
11,100 -6.1%
10.79
US$119,769 		11,100 -6.1% 10.79 US$119,769
2024-08-30 2024-08-30 PrS Proposed sale
2.7
Swift James D

Officer

Officer
11,100
10.79
US$119,756 		11,100 10.79 US$119,756
2024-08-29 2024-08-27 S Sale
2.5
Linynsky Laura A
Non-Executive Director
7,000 -18.5%
11.16
US$78,120 		7,000 -18.5% 11.16 US$78,120
2024-08-27 2024-08-27 PrS Proposed sale
2.5
Linynsky Laura A

Director

Non-Executive Director
7,000
11.16
US$78,134 		7,000 11.16 US$78,134
2024-08-13 2024-08-12 S Sale
0.9
Richards C Marc

EVP, Chief Financial Officer

Officer
17,438 -9.0%
10.08
US$175,775 		17,438 -9.0% 10.08 US$175,775
2024-08-13 2024-08-09 S Sale
0.9
Richards C Marc

EVP, Chief Financial Officer

Officer
32,562 -14.4%
10.08
US$328,225 		32,562 -14.4% 10.08 US$328,225
2024-08-09 2024-08-09 PrS Proposed sale
2.8
Wood Lee

Former Officer

Officer
47,230
10.25
US$484,158 		47,230 10.25 US$484,158
2024-08-09 2024-08-09 PrS Proposed sale
0.9
Richards C Marc

Officer

Officer
50,000
10.05
US$502,590 		50,000 10.05 US$502,590
2023-12-15 2023-12-14 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
5,764 -6.0%
9.58
US$55,219 		5,764 -6.0% 9.58 US$55,219
2023-12-15 2023-12-14 S Sale
3.5
Moore Mary Ann E

EVP, General Counsel & Sec

Officer
970 -1.2%
9.62
US$9,331 		970 -1.2% 9.62 US$9,331
2023-12-15 2023-12-14 S Sale
3.5
Moore Mary Ann E

EVP, General Counsel & Sec

Officer
1,150 -6.8%
9.62
US$11,063 		1,150 -6.8% 9.62 US$11,063
2023-12-14 2023-12-14 PrS Proposed sale
2.7
Swift James D

Officer

Officer
5,764
9.58
US$55,220 		5,764 9.58 US$55,220
2023-06-16 2023-06-14 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
13,193 -12.0%
14.14
US$186,549 		13,193 -12.0% 14.14 US$186,549
2023-06-14 2023-06-14 PrS Proposed sale
2.7
Swift James D

Officer

Officer
13,193
14.14
US$186,575 		13,193 14.14 US$186,575
2023-05-26 2023-05-25 S Sale
3.2
ORDAN MARK S
Non-Executive Director
33,000 -18.2%
13.26
US$437,580 		33,000 -18.2% 13.26 US$437,580
2023-05-24 2023-05-24 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
33,000
13.53
US$446,490 		33,000 13.53 US$446,490
2023-05-22 2023-05-19 S Sale
2.0
Weis Shirley A
Non-Executive Director
1,007 -5.4%
13.63
US$13,725 		1,007 -5.4% 13.63 US$13,725
2023-05-19 2023-05-19 PrS Proposed sale
2.0
Weis Shirley A

Director

Non-Executive Director
1,007
13.63
US$13,726 		1,007 13.63 US$13,726
2023-05-22 2023-05-18 S Sale
2.0
Weis Shirley A
Non-Executive Director
17,993 -49.1%
13.55
US$243,805 		17,993 -49.1% 13.55 US$243,805
2023-05-18 2023-05-18 PrS Proposed sale
2.0
Weis Shirley A

Director

Non-Executive Director
17,993
13.55
US$243,885 		17,993 13.55 US$243,885
2023-05-12 2023-05-12 PrS Proposed sale
Roger J. Medel

Affiliate
227,734
13.50
US$3,074,409 		227,734 13.50 US$3,074,409
2023-05-10 2023-05-10 PrS Proposed sale
Roger J. Medel. M.D.

Affiliate
50,000
13.50
US$675,000 		50,000 13.50 US$675,000
2022-11-23 2022-11-21 S Sale
3.2
ORDAN MARK S

Chief Executive Officer

Executive Director
22,166 -6.0%
15.45
US$342,465 		22,166 -6.0% 15.45 US$342,465
2022-11-09 2022-11-07 S Sale
2.7
Swift James D

EVP, Chief Operating Officer

Officer
24,000 -21.4%
15.31
US$367,440 		24,000 -21.4% 15.31 US$367,440
2022-01-11 2022-01-11 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
40,107 -5.1%
26.58
US$1,066,044 		40,107 -5.1% 26.58 US$1,066,044
2022-01-11 2022-01-10 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
59,893 -7.1%
26.44
US$1,583,571 		59,893 -7.1% 26.44 US$1,583,571
2022-01-07 2022-01-05 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
12,639 -1.5%
27.42
US$346,561 		12,639 -1.5% 27.42 US$346,561
2022-01-04 2022-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
87,361 -9.3%
27.43
US$2,396,312 		87,361 -9.3% 27.43 US$2,396,312
2022-01-04 2021-12-31 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
6,564 -0.7%
27.16
US$178,278 		6,564 -0.7% 27.16 US$178,278
2021-11-10 2021-11-10 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
5,000 -4.9%
28.45
US$142,250 		5,000 -4.9% 28.45 US$142,250
2021-11-10 2021-11-10 PlS Planned sale
Hinson Roger Mack

Pres., PDX & OBX Medical Group

Officer
8,800 -7.6%
28.38
US$249,744 		8,800 -7.6% 28.38 US$249,744
2021-10-29 2021-10-29 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
9,238 -8.3%
26.87
US$248,225 		9,238 -8.3% 26.87 US$248,225
2021-10-29 2021-10-28 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
10,387 -0.9%
29.00
US$301,223 		10,387 -0.9% 29.00 US$301,223
2021-10-06 2021-10-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
1,270 -0.1%
29.00
US$36,830 		1,270 -0.1% 29.00 US$36,830
2021-08-11 2021-08-10 PlS Planned sale
Hinson Roger Mack

Pres., PDX & OBX Medical Group

Officer
8,799 -7.0%
32.35
US$284,648 		8,799 -7.0% 32.35 US$284,648
2021-04-02 2021-04-01 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
782 -0.1%
25.81
US$20,183 		782 -0.1% 25.81 US$20,183
2021-04-02 2021-04-01 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
99,218 -7.0%
25.40
US$2,520,137 		99,218 -7.0% 25.40 US$2,520,137
2021-01-05 2021-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
52,961 -3.4%
23.89
US$1,265,238 		52,961 -3.4% 23.89 US$1,265,238
2021-01-05 2021-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
47,039 -3.0%
23.41
US$1,101,183 		47,039 -3.0% 23.41 US$1,101,183
2020-12-11 2020-12-10 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
33,194 -2.0%
23.04
US$764,919 		33,194 -2.0% 23.04 US$764,919
2020-12-11 2020-12-09 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
66,806 -4.0%
23.00
US$1,536,672 		66,806 -4.0% 23.00 US$1,536,672
2020-09-17 2020-09-15 S Sale
3.1
Andreano Dominic J

EVP, General Counsel and Secy

Officer
22,000 -29.1%
18.93
US$416,425 		22,000 -29.1% 18.93 US$416,425
2020-09-17 2020-09-15 S Sale
1.6
Nikolopoulos Nicholas J

EVP Chf Strategy & Growth Offi

Officer
10,000 -12.2%
19.02
US$190,179 		10,000 -12.2% 19.02 US$190,179
2019-11-01 2019-11-01 PlS Planned sale
3.1
Goldschmidt, MD Pascal J
5,000 -31.6%
22.88
US$114,403 		5,000 -31.6% 22.88 US$114,403
2019-09-04 2019-09-03 PlS Planned sale
3.1
Goldschmidt, MD Pascal J
5,000 -24.0%
20.81
US$104,050 		5,000 -24.0% 20.81 US$104,050
2019-08-13 2019-08-12 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
61,204 +32.4%
21.35
US$1,306,816 		61,204 +32.4% 21.35 US$1,306,816
2019-08-13 2019-08-12 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
61,205 +21.2%
21.35
US$1,306,837 		61,205 +21.2% 21.35 US$1,306,837
2019-08-12 2019-08-09 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
124,553 +193.9%
21.52
US$2,680,879 		124,553 +193.9% 21.52 US$2,680,879
2019-08-12 2019-08-09 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
124,553 +75.7%
21.52
US$2,680,879 		124,553 +75.7% 21.52 US$2,680,879
2019-08-12 2019-08-08 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
64,243 +inf%
21.68
US$1,392,596 		64,243 +inf% 21.68 US$1,392,596
2019-08-12 2019-08-08 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
64,242 +64.1%
21.68
US$1,392,574 		64,242 +64.1% 21.68 US$1,392,574
2019-03-15 2019-03-13 S Sale
3.1
Goldschmidt, MD Pascal J
Non-Executive Director
3,300 -13.7%
30.40
US$100,331 		3,300 -13.7% 30.40 US$100,331
2019-03-08 2019-03-07 PlS Planned sale
3.1
Andreano Dominic J

SVP, General Counsel and Secy
4,608 -6.7%
30.16
US$138,984 		4,608 -6.7% 30.16 US$138,984
2019-03-01 2019-03-01 PlS Planned sale
CALABRO JOSEPH M

President

Officer
12,130 -2.7%
32.91
US$399,197 		12,130 -2.7% 32.91 US$399,197
2019-03-01 2019-03-01 PlS Planned sale
Clark David A.

Chief Operating Officer

Officer
6,452 -4.5%
32.90
US$212,262 		6,452 -4.5% 32.90 US$212,262
2019-02-22 2019-02-20 PlS Planned sale
3.1
Andreano Dominic J

SVP, General Counsel and Secy

Officer
1,289 -1.8%
36.22
US$46,690 		1,289 -1.8% 36.22 US$46,690
2019-01-23 2019-01-22 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
2,500 -8.0%
36.60
US$91,500 		2,500 -8.0% 36.60 US$91,500
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
1,025 -3.6%
48.20
US$49,405 		1,025 -3.6% 48.20 US$49,405
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
1,540 -5.1%
48.18
US$74,197 		1,540 -5.1% 48.18 US$74,197
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
935 -3.0%
48.17
US$45,039 		935 -3.0% 48.17 US$45,039
2018-06-13 2018-06-12 S Sale
3.3
Lopez-Blanco Vivian

Chief Financial Officer

Officer
13,942 -12.2%
46.46
US$647,775 		13,942 -12.2% 46.46 US$647,775
Explore more

More insider trading research around Pediatrix Medical Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America